Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin AnalogTip Ranks·2 days ago, 09:38 AM01276-0.52%600276-1.04%
Nomura Cuts HENGRUI PHARMA TP to HKD82.18, Lowers FY2026 Revenue and Profit ForecastsAASTOCKS News·Jul 26 at 10:29 PM01276-0.52%600276-1.04%
As weight-loss drug orders surge, global funds pile into China’s WuXi AppTecSCMP·Jul 24 at 05:39 AM02359+1.90%603259+2.35%
Hengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line UseTip Ranks·Jul 23 at 07:37 AM01276-0.52%600276-1.04%
Hengrui Pharma wins China approval for camrelizumab-famitinib combo as 1L cervical cancer treatmentPUBT·Jul 23 at 07:32 AM01276-0.52%600276-1.04%
WuXi AppTec joins FTSE4Good Index Series for fourth straight yearPUBT·Jul 21 at 06:54 PM02359+1.90%603259+2.35%
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Receives a Buy from Morgan StanleyTip Ranks·Jul 17 at 07:27 PM01276-0.52%600276-1.04%
IDEAYA shares ESMO 2026 data updates for darovasertib trials in uveal melanomaPUBT·Jul 17 at 08:00 AMIDYA-2.47%01276-0.52%
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs | IDYA Stock NewsStockTitan·Jul 17 at 12:00 AMIDYA-2.47%600276-1.04%
CLSA Sticks to Its Buy Rating for WuXi AppTec Co., Ltd. Class H (2359)Tip Ranks·Jul 16 at 07:26 PM02359+1.90%603259+2.35%
HSI Up 340 pts; HSTI Up 61 pts; MEITUAN Up over 5%; TENCENT Up over 3%; WUXI APPTEC, HSBC HOLDINGS, ABLE DIGITAL Hit New Highs; Market Turnover RisesAASTOCKS News·Jul 15 at 03:20 AM03690-0.16%02359+1.90%
HSI Up 354 pts; HSTI Up 64 pts; MEITUAN Up over 4%; TENCENT Up over 3%; WUXI APPTEC, HSBC HOLDINGS, ABLE DIGITAL Hit New HighsAASTOCKS News·Jul 14 at 11:16 PMHSBA603259+2.35%
UBS: CN CRO Sees Solid Revenue Growth in 1H; WUXI APPTEC Top PickAASTOCKS News·Jul 14 at 02:56 AM02269+2.49%02359+1.90%
UBS' Investment Ratings and TPs on CRO Stocks (Table)AASTOCKS News·Jul 14 at 02:00 AM300759+2.19%02268+1.47%
S&P Global Market Intelligence Lists Latest Top 10 Most Shorted Hong Kong Stocks by Short Interest RatioAASTOCKS News·Jul 13 at 09:30 PM300433+2.43%ZTCOY0.00%